Alligator: "We're standing out very clearly"
Автор: BioStock
Загружено: 2025-05-05
Просмотров: 3399
Alligator Bioscience is offering the exercise of Series TO 12 subscription warrants from 5 to 19 May 2025. In connection with this, CEO Søren Bregenholt is interviewed by BioStock to provide deeper insight into the significance of the warrant program and its role in the company's long-term financing strategy. The interview also covers the clinical development of mitazalimab, a drug candidate that has shown promising results to date, as well as Alligator's future vision for the project. Additionally, Bregenholt shares how the company plans to differentiate itself in the current financial climate within the biotech sector.
0:00 Introduction
0:27 Importance of warrants
1:07 Financial strategy
1:41 Mitazalimab - findings and next steps
2:24 Long-term vision
3:07 How to stand out
3:54 Message to investors
Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn: / biostock
Facebook: / biostock.se
https://www.biostock.se/
#BioStock #LifeScience #AlligatorBioscience
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: